Eiger BioPharmaceuticals, Inc. (EIGRQ) Stock Analysis
DELISTED
What happened to Eiger BioPharmaceuticals, Inc. (EIGRQ) stock?
Eiger BioPharmaceuticals, Inc. (EIGRQ) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
Market cap $12.6M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Eiger BioPharmaceuticals, Inc. (EIGRQ). Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on developing therapies for hepatitis delta virus (HDV) and other serious diseases. The company filed for Chapter 11 reorganization in April 2024.
Last analyzed: Mar 16, 2026Eiger BioPharmaceuticals, Inc. (EIGRQ) Healthcare & Pipeline Overview
EIGRQ OTC Market Information
EIGRQ trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy EIGRQ shares?
No. EIGRQ stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for EIGRQ elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before EIGRQ stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Eiger BioPharmaceuticals, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.